Alerts will be sent to your verified email
Verify Email
NATCOPHARM
|
Natco Pharma
|
Caplin Point Lab
|
Jubilant Pharmova
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.06 % | 20.61 % | 7.82 % |
|
5yr Avg Net Profit Margin
|
23.09 % | 24.8 % | 6.45 % |
|
Price to Book
|
2.04 | 9.42 | 2.65 |
|
P/E
|
9.12 | 45.43 | 35.98 |
|
5yr Avg Cash Conversion Cycle
|
10.54 Days | 79.85 Days | -39.98 Days |
|
5yr Average Interest Coverage Ratio
|
60.49 | 579.71 | 3.78 |
|
5yr Avg ROCE
|
16.05 % | 25.27 % | 8.15 % |
|
5yr Avg Operating Profit Margin
|
30.17 % | 30.87 % | 16.76 % |
|
5 yr average Debt to Equity
|
0.06 | 0.01 | 0.55 |
|
5yr CAGR Net Profit
|
33.73 % | 16.28 % | 0.08 % |
|
5yr Average Return on Assets
|
11.07 % | 17.7 % | 4.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.56 % | 70.56 % | 47.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.76 % | 1.68 % | -3.0 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-4.64 % | 0.87 % | 5.97 % |
|
Natco Pharma
|
Caplin Point Lab
|
Jubilant Pharmova
|
|---|